ATE314073T1 - Kombination von aktiva mit alfuzosin und apomorphin - Google Patents

Kombination von aktiva mit alfuzosin und apomorphin

Info

Publication number
ATE314073T1
ATE314073T1 AT02711823T AT02711823T ATE314073T1 AT E314073 T1 ATE314073 T1 AT E314073T1 AT 02711823 T AT02711823 T AT 02711823T AT 02711823 T AT02711823 T AT 02711823T AT E314073 T1 ATE314073 T1 AT E314073T1
Authority
AT
Austria
Prior art keywords
alfuzosine
apomorphine
combination
actives
ameliorating
Prior art date
Application number
AT02711823T
Other languages
English (en)
Inventor
Sonia Arbilla
Juan Fernando Ramirez
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Application granted granted Critical
Publication of ATE314073T1 publication Critical patent/ATE314073T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Glass Compositions (AREA)
  • Saccharide Compounds (AREA)
AT02711823T 2001-01-19 2002-01-18 Kombination von aktiva mit alfuzosin und apomorphin ATE314073T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01400166A EP1224933A1 (de) 2001-01-19 2001-01-19 Neue Kombination mit Alfuzosin und Apomorphin als Aktiva
PCT/EP2002/001051 WO2002056887A1 (en) 2001-01-19 2002-01-18 New combination of active ingredients containing alfuzosine and apomorphine

Publications (1)

Publication Number Publication Date
ATE314073T1 true ATE314073T1 (de) 2006-01-15

Family

ID=8182601

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02711823T ATE314073T1 (de) 2001-01-19 2002-01-18 Kombination von aktiva mit alfuzosin und apomorphin

Country Status (10)

Country Link
US (1) US20040063736A1 (de)
EP (2) EP1224933A1 (de)
JP (1) JP2004517141A (de)
AT (1) ATE314073T1 (de)
DE (1) DE60208336T2 (de)
DK (1) DK1355650T3 (de)
ES (1) ES2254657T3 (de)
PT (1) PT1355650E (de)
SI (1) SI1355650T1 (de)
WO (1) WO2002056887A1 (de)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5482039A (en) * 1994-03-25 1996-01-09 Vivus, Inc. Process for diagnosing erectile dysfunction, and related methods of treatment
CA2188385C (en) * 1994-04-22 2000-07-11 Ragab El-Rashidy Dosage forms and method for ameliorating male erectile dysfunction
US6043252A (en) * 1997-05-05 2000-03-28 Icos Corporation Carboline derivatives
JP2003525845A (ja) * 1997-10-28 2003-09-02 ヴィヴァス・インコーポレイテッド 勃起機能不全の処置のためのホスホジエステラーゼインヒビターの局所投与

Also Published As

Publication number Publication date
US20040063736A1 (en) 2004-04-01
EP1224933A1 (de) 2002-07-24
JP2004517141A (ja) 2004-06-10
PT1355650E (pt) 2006-05-31
DE60208336T2 (de) 2006-09-07
EP1355650B1 (de) 2005-12-28
ES2254657T3 (es) 2006-06-16
SI1355650T1 (sl) 2006-06-30
DE60208336D1 (de) 2006-02-02
WO2002056887A1 (en) 2002-07-25
DK1355650T3 (da) 2006-05-15
EP1355650A1 (de) 2003-10-29

Similar Documents

Publication Publication Date Title
DE60127277D1 (de) Zusammensetzung zur transdermalen und/oder transmukosalen Verabreichung von Wirkstoffen, die ausreichende therapeutische Spiegel garantiert
SE0102315D0 (sv) Compounds
TW200626526A (en) Pharmaceutical compositions for the treatment of neoplasms
DK1411932T3 (da) Kombinationsterapi med substituerede oxazolidinoner
DE60235083D1 (de) Substituierte tetracyclin-verbindungen zur behandlung von malaria
BR0207961A (pt) Combinação de análogos da epotilona e agentes quimioterápicos para o tratamento de doenças proliferativas
HUP0301868A2 (hu) Gyógyászati készítmény, ami VIIa és XIII-as faktort tartalmaz
AR034231A1 (es) Composicion farmaceutica que contiene mosaprida y pancreatina
BG66080B1 (bg) Заместени тиоацетамиди
EA200300929A1 (ru) Новые лекарственные композиции на основе антихолинергических средств и ингибиторов pde-iv
DK1411938T3 (da) Anvendelse af cyclopamin til fremstilling af et medikament til behandling af psoriasis
EA200501690A1 (ru) Композиция, включающая ингибитор pde4 и ингибитор pde5
ATE495793T1 (de) Antitumorzusammensetzungen welche ecteinascidin 743 enthalten
BRPI0509140A (pt) processos para o tratamento de infecção por hiv
DE60132851D1 (de) Arzneimittel zur Vorbeugung, Erleichterung oder Behandlung von Hypertension
ATE432068T1 (de) Cetirizin und pseudoephedrin enthaltende tablette
DE50206761D1 (de) Fluorhaltige copolymere, deren herstellung und verwendung
ATE212841T1 (de) Yohimbine und arginin enthaltende zusammensetzung zur behandlung der erektilen fehlfunktion
EA200400436A1 (ru) Медикаменты для профилактики и лечения бромидроза
EE200300213A (et) SARP-1 kasutamine sklerodermia raviks ja/või ennetamiseks
MX9403032A (es) Quinolil-dihidropiridinas condensadas, procedimiento para su fabricacion ysu uso en medicamentos.
DE60213234D1 (de) 4-(penylpiperidin-4-ylidenmethyl)benzamidderivate und deren verwendung zur behandlung von schmerzen, angstzuständen oder erkrankungen des magen-darm-trakts
SE0001916D0 (sv) Novel formulation
JO3446B1 (ar) طريقة لمعالجة الأرق الأولي
DE60208336D1 (de) Kombination von aktiva mit alfuzosin und apomorphin

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1355650

Country of ref document: EP

REN Ceased due to non-payment of the annual fee